| Here are the final standings. 
 By Portfolio Value at 12/16/2005
 1	Richard Harmon     	$165,844 	65.8%
 2	Bob Cryan          	$138,592 	38.6%
 3	RCMac              	$129,938 	29.9%
 4	tom pope           	$114,514 	14.5%
 5	nigel bates        	$111,943 	11.9%
 6	BulbaMan           	$111,035 	11.0%
 7	mopgcw             	$109,970 	10.0%
 8	rkrw               	$108,386 	8.4%
 9	Mike McFarland     	$104,303 	4.3%
 10	georgiabiotech     	$104,053 	4.1%
 11	bio_kruncher       	$97,756 	-2.2%
 12	Miljenko Zuanic    	$91,008 	-9.0%
 13	FiloF              	$90,515 	-9.5%
 14	hopper             	$89,412 	-10.6%
 15	Rocky9             	$87,253 	-12.7%
 16	Biomaven           	$86,389 	-13.6%
 17	Biotech Jim        	$84,037 	-16.0%
 18	Jorgen Jensen      	$83,597 	-16.4%
 19	Robert C. Jonson   	$82,680 	-17.3%
 20	former_pgs         	$80,458 	-19.5%
 21	manny_velasco      	$79,569 	-20.4%
 22	TexasDude          	$79,366 	-20.6%
 23	zeta1961           	$78,902 	-21.1%
 24	quidditch          	$78,259 	-21.7%
 25	Archimedes         	$78,199 	-21.8%
 26	fred hayes         	$75,826 	-24.2%
 27	Extra Pale         	$73,854 	-26.1%
 28	WilderElisimo      	$73,392 	-26.6%
 29	jackelmq           	$72,948 	-27.1%
 30	biotek-al          	$72,728 	-27.3%
 31	Icebrg             	$71,022 	-29.0%
 Aggregate       	$2,905,746 	-6.3%
 
 
 Based on these results, in addition to the top 3, kudos should also have gone out to Tom, Nigel, Bulba, mopgcw, rkrw, Mike McFarland and georgiabiotech for finishing in  the black (sorry it has taken so long).
 
 Let me know if you see any errors so they can be corrected for posterity -- I could have easily made a few, especially in connection with the munches (see below for detail).  And I apologize in advance if an error makes you look bad<g>.
 
 Adjustments made since the Sep 30 results:
 BIO.L munched for.225 shares of GLPG.L for each BIO.L share.
 AEGN munched for $.75/share.
 GLFD munched for .1103 shares of MOGN and $1.125 cash.
 IDBE munched for $30.27 USD ($35 CAD).
 GNSC munched for .065 shares of CLDA.
 |